tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedAdvisor Limited Announces Strategic Board Changes Post-ANZ Sale

Story Highlights
MedAdvisor Limited Announces Strategic Board Changes Post-ANZ Sale

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

MedAdvisor Limited ( (AU:MDR) ) has issued an announcement.

MedAdvisor Limited announced board changes following the sale of its ANZ business, reflecting a significant change in the company’s scale. Non-Executive Directors Jim Xenos and Kevin Hutchinson have stepped down, with Hutchinson continuing in an advisory role for the US strategic review. Sean Slattery, the recently appointed CFO, joins the board as an Executive Director, bringing extensive financial expertise and experience in US operations. These changes aim to align the board with the company’s current scale and geographic focus, as MedAdvisor continues to explore strategic options.

The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.

More about MedAdvisor Limited

MedAdvisor Solutions is a leader in pharmacy-driven patient engagement solutions, providing personalized experiences to simplify the patient medication journey. The company leverages THRiV, a cloud-based, AI-enabled platform, to enhance pharmacy workflow and patient engagement. MedAdvisor Solutions collaborates with over 34,000 pharmacies across the US, reaching more than two-thirds of the population.

Average Trading Volume: 955,572

Technical Sentiment Signal: Sell

Current Market Cap: A$34.39M

See more data about MDR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1